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It has been previously shown that local administration of a high dose of morphine together
with a proinflammatory agent has anti-inflammatory effects in several (but not all) strains of
mice. In the present paper, behavioural and cellular consequences of morphine co-injection
are compared between several strains of mice with zymosan-induced peritonitis. Males of
C57C3H, Swiss, Balb/c, C57BL/6, and CBA strains were ip injected with Zymosan (40
mg/kg) and/or morphine at 0, 5, 10, 20 mg/kg without or with naltrexone pretreatment. Early
stages of Zymosan-induced peritonitis were connected with intraperitoneal accumulation of
leukocytes (mainly PMNs), pain symptoms (body writhes of strain-specific frequency:
C57C3H>CBA>Swiss>>Balb/c~C57BL/6), and sedation (significant in Swiss and Balb/c).
Morphine co-injection abolished pain symptoms at all doses in every investigated strain, and
restored locomotor activity or induced hyperlocomotion in a dose- and strain-specific
manner. The highest dose of morphine inhibited intraperitoneal accumulation of peritoneal
leukocytes (PTLs) including polymorphonuclear cells (PMNs) in all but the CBA strain of
mice. Anti-inflammatory and anti-nociceptive effects of morphine were reversed in
naltrexone pre-treated animals. The pre-incubation of Swiss but not CBA leukocytes with
morphine inhibited cell chemotaxis towards zymosan-activated serum. In conclusion,
morphine exerts various strain-specific effects on peritonitis.
Key words: Peritonitis, pain symptoms, locomotor activity, CBA, Balb/c, C57BL/6,
C57C3H, Swiss mice.
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It has been previously shown that the supple-
mentation of a proinflammatory agent with a high
dose of morphine not only attenuated pain but also
inhibited influx of leukocytes to the focus of in-
flammation during Zymosan-induced peritonitis
in mice (PLYTYCZ & NATORSKA 2002). Such
antinociceptive and anti-inflammatory effects of
local morphine administration might offer benefits
during planned surgeries, thus the underlying
mechanisms are worth of study. At the early stages
of Zymosan-induced peritonitis, it was recorded
that the intraperitoneal accumulation of endoge-
nous opioids related to their influx from closely lo-
cated lymph nodes and some brain areas (CHA-
DZINSKA et al. 2003) and/or to their local synthe-
sis/release by inflammatory leukocytes (CHADZIN-
SKA et al. 2001), as evidenced also in other models
of inflammation (CABOT et al. 1997; PRZEWLOCKI
et al. 1992; STEIN et al. 2001). It seems that local
administration of exogenous morphine might sup-
port and/or replace the anti-nociceptive action of
endogenous opioids in the focus of inflammation
and, as a consequence, might limit a chemotactic
influx/accumulation of new leukocytes.
Anti-inflammatory effects of morphine were
originally recorded in some strains of laboratory
mice (PLYTYCZ & NATORSKA 2002; CHADZIN-
SKA et al. 1999), in salmon (CHADZINSKA et al.
1999) and goldfish (CHADZINSKA et al. 2000), but
in none of the investigated species of anuran am-
phibians (KOLACZKOWSKA et al. 2000). Such in vivo
sensitivity or resistance to the anti-inflammatory
action of morphine corresponded with the in vitro
migratory activity of morphine-treated leukocytes
towards some chemoattractants; pre-incubation
with morphine inhibited migration of mouse and
fish leukocytes but not of frog leukocytes to che-
motactic factors present in Zymosan-activated se-
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rum (CHADZINSKA & PLYTYCZ 2004). During our
ongoing series of experiments it turned out, how-
ever, that anti-inflammatory and anti-chemotactic
effects of morphine are not shared even by the
laboratory strains of mice, as they are absent in
males of the CBA strain (STANKIEWICZ et al. 2001),
perhaps due to the peculiar features of CBA mast
cells (STANKIEWICZ et al. 2004). The aim of the pres-
ent paper was to compare some behavioural and
cellular effects of morphine co-injection on males
of several strains of mice with Zymosan-induced
peritonitis.
Material and Methods
Animals
Adult males (6-8 week-old) of Swiss, Balb/c,
C57BL/6, and CBA strains were purchased from
the Unit of Laboratory Animals (Collegium Medi-
cum, Jagiellonian University, Kraków, Poland).
Males of C57C3H mice were obtained from the
departmental breeding colony, and originated
from the random mating of F2 progeny of
C57BLC3H mice (SCISLOWSKA-CZARNECKA et al.
2004). The animals were kept in cages 201318 cm
under controlled temperature (22oC) and lighting
(lights on 8:00-20:00), 4 individuals per cage.
Food (mouse chow) and water were available ad
libitum. The ethical guidelines by the local com-
mittee on animal care (license no. 16/OP/2001)
were followed throughout the experiments.
In vivo experimental procedures
After one-week adaptation to the laboratory con-
ditions, the animals were ip injected at 10:00 a.m.
with 0.5 ml/25 g b.w. of 2% Zymosan A (40 mg/kg
b.w.) (Sigma, London, UK) supplemented with
morphine hydrochloride (0, 5, 10 or 20 mg/kg
b.w., Polfa, Kutno, Poland) or with the same doses
of morphine only, in some instances 20 min after ip
injection with naltrexone hydrochloride (1 mg/kg
b.w.) (Sigma, London, UK). Immediately after zy-
mosan and/or morphine injection, each mouse was
placed in a separate cage with a floor covered with
a sheet of checked paper. Behaviour, namely body
writhing (DOHERTY et al. 1987) and crossings
over the transverse line (called crossovers) were
scored for 45 minutes by a trained observer unin-
formed of the animals’ experimental treatment.
Then the animals were transferred to the original
cages with a routine bedding, 4 per cage. Each mouse
was used only once. The animals were sacrificed
by cervical dislocation at time 0 (intact controls) or
4 hours after Zymosan injection (at 2:00 p.m.) and
their peritoneal cavities were lavaged with 1 ml PBS.
The retrieved exudatory leukocytes were stained
with Turk’s stain and counted in a haemocytome-
ter. Experiments were repeated at least three times
with 4 animals per each experimental group.
In vitro migratory assay
Bone marrow cells from the intact Swiss and
CBA mice were collected in 2 ml of RPMI 1640
medium and the cell concentration was adjusted to
5x106 cells/ml. Cells were incubated for 5 min in
10-8 M morphine in RPMI or in RPMI only (con-
trol). Serum from intact mice was activated by a
30-minute incubation with zymosan (20mg/ml,
Sigma, London UK) at 37oC followed by centrifu-
gation and heat-inactivation (56oC, 30 min).
Heat-inactivated serum (without prior activation)
or RPMI 1640 (Sigma, London, UK) served as a
control.
A 48-well microchemotaxis chamber (Neuro
Probe, Inc., Maryland, USA) was used to assess
the leukocyte migratory activity (e.g. see CHADZ-
INSKA & PLYTYCZ 2004). The lower wells of the
apparatus were filled with 27 l of Zymosan acti-
vated serum (ZAS) as a source of chemotactic fac-
tors, or heat-inactivated serum or medium, serving
as controls. Then the bottom part of the apparatus
was covered with nitro-cellulose filters (Nucleo-
pore membrane, Neuro Probe INC., MD, USA),
5m pore size. The upper wells were filled with 50l
of leukocyte suspension from the bone marrow.
Chambers were incubated for 3 hrs at 37oC, and
then the cells remaining on the upper surface of the
filter were removed. Filters were fixed in 4% buff-
ered formaline, stained with Harris’s hematox-
yline (40 min), washed in water (10 min) and
cleared in xylene (15 min). Cells migrating through
the filter were counted using a 40 objective. The
results were expressed as the percentage of migra-
tory cells = (mean number of cells migrating to-
wards ZAS / mean number of cells migrating
towards RPMI 1640)  100%. Experiments were
repeated three times with triplicate samples in
each group.
Statistical analysis
All results were expressed as means (SE) and
analysed according to Tukey’s test with a signifi-
cance threshold at P<0.05.
Results and Discussion
Intact mice of all investigated strains possessed
the lowest number of resident peritoneal leuko-
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cytes (PTLs). A massive accumulation of exuda-
tory PTLs, among them polimorphonuclear cells
(PMNs), was evident in the animals of all strains
investigated 4 hours after Zymosan injection. In
CBA mice, the numbers of exudatory PTLs and
PMNs were not affected by the morphine co-
injection at any dose applied here. In contrast, the
co-injection with the highest dose of morphine (20
mg/kg b.w.) caused a significant decrease of PTLs
(among them PMNs) in the four remaining strains
(see “A” versus “B” in Figs 1a,b). In C57BL/6 ani-
mals, the numbers of PMNs were already signifi-
cantly decreased by the lower doses of morphine
(5 and 10 mg/kg b.w.) (see “C” versus “B” in Fig.
1b).
Animals with peritonitis (but not their intact
counterparts) exhibited characteristic body writhes
(consisting of a contraction of the abdominal mus-
cles together with a stretching of hind limbs) con-
sidered to be pain symptoms (SCISLOWSKA-CZAR-
NECKA et al. 2004; DOHERTY et al. 1987; RIBEIRO
et al. 2000). The number of such writhes was high
during the first half-an-hour after Zymosan injec-
tion, while thereafter these symptoms were spo-
radic only (SCISLOWSKA-CZARNECKA et al.
2004). For statistical comparisons the cumulative
numbers of writhes occurring between 0 and 45
min after zymosan injection were used. The fre-
quency of the body writhes was in the order:
C57C3H>CBA>Swiss>>Balb/c~C57BL/6 (Fig. 2),
thus did not correspond with the pattern of intrape-
ritoneal leukocyte accumulation, including PMNs,
which at 4 hrs after zymosan injection was in the
order:C57C3H>Swiss~Balb/c>C57BL/6>CBA(Fig.1).
Morphine co-injection at all doses applied here
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Fig. 1. Effects of morphine co-injection on Zymosan-induced peritonitis in males of C57C3H, Swiss, BALB/c, C57BL/6, and
CBA mice. Z, ZM – animals ip injected with Zymosan (40 mg/kg b.w.) supplemented with morphine (5, 10, 20 mg/kg b.w.);
INT – intact animals. Means ± SE (n=8-12). Means with different letters vary significantly according to Tukey’s test
(P<0.05). (a) Numbers of peritoneal leukocytes (PTLs), and (b) polymorphonuclear leukocytes (PMNs), 4 hrs after ip
injection.
Fig. 2. Pain symptoms (cumulative numbers of body writhes/45 min) during Zymosan-induced peritonitis in males of
C57C3H, Swiss, BALB/c, C57BL/6, and CBA mice. Means ± SE (n=8-12). Means with different letters vary significantly
according to Tukey’s test (P<0.05).
Fig. 3. Effects of morphine on locomotor activity (cumulative numbers of crossovers/45 min) in males of C57C3H, Swiss,
BALB/c, C57BL/6, and CBA mice with morphine-modulated Zymosan-induced peritonitis (top) and their counterparts
treated with morphine only (bottom). ZM – animals ip injected with Zymosan (40 mg/kg b.w.) supplemented with morphine
(0, 5, 10, 20 mg/kg b.w.); M – animals ip injected with with morphine only (5, 10, 20 mg/kg b.w.); INT – intact animals.
Means ± SE (n=8-12). Means with different letters vary significantly according to Tukey’s test (P<0.05).
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abolished the pain symptoms almost completely in
all investigated strains (data not shown).
In all strains the inflammation-related pain
symptoms corresponded with the suppression of
animal mobility when compared with that of the
intact mice exposed to the novel environment
(PAOLONE et al. 2003). Such inflammation-related
hypolocomotion was significant in Swiss and Balb/c
(Fig. 3). In all strains, sedation characteristic for
the early stages of ongoing peritonitis was re-
versed by the morphine co-injection. In this re-
spect morphine was efficient already at the lowest
dose in all but the Balb/c strain, where higher doses
were necessary for anti-sedative effects. Moreo-
ver, morphine co-injection with Zymosan induced
hyperlocomotion of C57C3H and Swiss animals
measured by intensive animal crossovers (Fig. 3,
top).
Injection of animals only with morphine induced
hyperlocomotion in five investigated strains, which
was significant in three of them: C57C3H, Swiss,
and Balb/c (Fig. 3, bottom). Such morphine-
induced changes of animal locomotor activity are
well known in rodents (COOK & BEARDSLEY
2003; MANZANEDO et al. 2004). Present results
show that morphine-induced hyperactivity is little
affected by the ongoing inflammatory process in
C57C3H and Swiss mice, while it is inhibited in
Balb/c, C57BL/6 and CBA animals (Fig. 3 top and
bottom). In conclusion, morphine affects the loco-
motor activity of animals with peritonitis in a
strain-specific manner.
In animals injected with naltrexone 20 minutes
before ZM ip injection, both anti-nociceptive and
anti-inflammatory effects of morphine were com-
pletely reversed while naltrexone itself induced
neither PTL accumulation nor pain symptoms, as
exemplified in Swiss mice on Fig. 4. These results
prove that both anti-nociceptive and anti-
inflammatory effects of morphine are mediated
through opioid receptor binding.
Bone marrow leukocytes from CBA mice were
much more mobile in the presence of a chemoat-
tractant than their counterparts from Swiss ani-
mals (Fig. 5). Preincubation with morphine did not
affect migration of CBA cells towards chemotac-
Fig. 4. Effects of morphine and naltrexone injection on Zymosan-induced peritonitis in males of Swiss mice. (a) Numbers of
peritoneal leukocytes (PTLs) at 4th hour after Z or ZM injection. (b) Pain symptoms (cumulative numbers of body writhes/45
min). ZM20 – animals ip injected with Zymosan (40 mg/kg b.w.) supplemented with morphine (20 mg/kg b.w.); N – animals
ip injected with naltrexone (1 mg/kg b.w.); NZM20 – animals ip injected with naltrexone (1 mg/kg b.w.) 20 minutes before
injection of Zymosan with morphine; INT – intact animals. Means ± SE (n=8-12). Means with different letters vary
significantly according to Tukey’s test (P<0.05).
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tic factors present in Zymosan-activated serum,
while the same pre-treatment significantly inhib-
ited migration of Swiss leukocytes towards the
same chemoattractants (Fig. 5), the latter already
evidenced in a previous paper (CHADZINSKA &
PLYTYCZ 2004). The inhibition of Swiss leuko-
cyte chemotactic activity might be connected with
morphine-induced desensitisation of leukocyte re-
ceptors for some chemotactic factors (ROGERS et
al. 2000; CHADZINSKA & PLYTYCZ 2004). The
lack of morphine-induced inhibition of CBA leu-
kocyte migration to some chemoattractants pres-
ent in vivo in the focus of inflammation might be at
least partly responsible for the absence of anti-
inflammatory effects of morphine in this strain of
mice. The lack of cross-desensitisation of che-
mokine receptors in CBA mice might be con-
nected with the lower expression of opioid
receptors in this particular strain of mice (NATOR-
SKA et al. in progress).
It has been shown previously that the peritoneal
cavity of CBA mice is inhabited by an exceptionally
rich population of mast cells, which are much more
numerous than those in other investigated strains of
mice (CBA>Balb/c>C57BL>OUTBRED>>Swiss)
(STANKIEWICZ et al. 2001). Moreover, CBA mast
cells degranulate and release histamine upon mor-
phine treatment, while such morphine-induced de-
granulation and histamine release are not evident
in the Swiss mast cells (STANKIEWICZ et al. 2004).
Corollary, morphine-induced degranulation of a
rich peritoneal CBA mast cell population undoubt-
edly contributes to the lack of anti-inflammatory
effects of the drug in this particular strain of mice
(STANKIEWICZ et al. 2004). In sum, the peculiarity
of CBA strain resistance to anti-inflammatory ef-
fects of morphine is based on the lack of morphine-
induced inhibition of chemotaxis and on the abun-
dance of morphine-sensitive mast cells.
Summarising, the early stages of Zymosan-induced
peritonitis in male mice were accompanied by pain
manifested by body writhes of strain-specific fre-
quency, corresponding with animal hypoactivity.
These symptoms were reversed by the morphine
co-injection. In some (but not all) strains the ongo-
ing peritonitis did not abolish the strain-specific
morphine-induced hyperlocomotion. In addition
to anti-nociceptive action, the high dose of mor-
phine added to the pro-inflammatory agent inhib-
ited accumulation of exudatory PTLs (among
them PMNs) in males of some but not all strains of
mice. The lack of anti-inflammatory effects of
morphine in the CBA strain may be related to the
abundant population of peritoneal mast cells sensi-
tive to morphine-induced degranulation and to the
lack of morphine-induced inhibition of leukocyte
migration towards inflamed peritoneal cavity.
Other factors contributing to the lack of morphine-
induced inhibition of peritonitis in CBA strain are
being currently elucidated. In conclusion, local ad-
ministration of morphine together with the infla-
mmation-inducing agent exerts in mice several
dissociated modulatory effects that are strain-
specific.
Fig. 5. Effects of morphine preincubation on migration of Swiss and CBA bone marrow leukocytes towards
Zymosan-activated serum (ZAS). Leukocytes pre-incubated with medium (L+RPMI) or with morphine (L+M). Means ± SE
(n=6). Percentage of migrating cells = (cells migrating towards ZAS / cells migrating towards medium) x 100%. Means with
different letters vary significantly according to Tukey’s test (P<0.05).
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